The company said that preliminary Q4 revenue was up 39 percent year over year and full-year 2025 revenue increased 35 percent ...

Here we highlight a subset of our preferred stocks from the screener. Overview: Natera, Inc. is a diagnostics company that offers molecular testing services globally and has a market cap of $31.69 ...

Natera, Inc. (NASDAQ:NTRA) is one of the High Growth Large Cap Stocks to Buy Right Now. On December 18, the company announced publication of the findings from the randomized, phase III CALGB (Alliance ...

NEW YORK – The minimal residual disease testing market continued to grow in 2025 as the biomarker based on the detection and analysis of circulating tumor DNA becomes increasingly clinically validated ...